---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-123500"
form_type: "8-K"
ticker: "RNAZ"
cik: "0001829635"
company_name: "Transcode Therapeutics, Inc."
filed_at: "2025-12-22T23:59:59+00:00"
generated_at: "2026-05-16T12:27:04.837886+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# TransCode Therapeutics appoints Jack Stover to Board of Directors

## Summary
- Jack Stover appointed to Board effective Dec 19, 2025; joins Audit and Nominating Committees.
- Dr. Magda Marquet resigns from Audit Committee following Stover's appointment.
- Stover brings over 30 years life sciences leadership; currently Chairman of Traws Pharma (TRAW).
- Previously CEO of Antares Pharma (ANTR), led sale to Halozyme for over $900 million.
- Stover is designated as independent director and financial expert.

## SEC filing metadata
- accession: 0001104659-25-123500
- form_type: 8-K
- ticker: RNAZ
- cik: 0001829635
- company_name: Transcode Therapeutics, Inc.
- filed_at: 2025-12-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1829635/000110465925123500/0001104659-25-123500-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1829635/000110465925123500/tm2534017d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-123500
- JSON: https://secwatch.observer/filing/0001104659-25-123500.json
- Plain text: https://secwatch.observer/filing/0001104659-25-123500.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.